CN108586427A - The preparation method of Atorvastatin calcium intermediate - Google Patents

The preparation method of Atorvastatin calcium intermediate Download PDF

Info

Publication number
CN108586427A
CN108586427A CN201810653383.0A CN201810653383A CN108586427A CN 108586427 A CN108586427 A CN 108586427A CN 201810653383 A CN201810653383 A CN 201810653383A CN 108586427 A CN108586427 A CN 108586427A
Authority
CN
China
Prior art keywords
compound
preparation
solution
reaction
atorvastatin calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201810653383.0A
Other languages
Chinese (zh)
Other versions
CN108586427B (en
Inventor
陈本顺
周长岳
石利平
成洪业
徐春涛
万新强
何义
毛玲妙
李娜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu alpha Pharmaceutical Co.,Ltd.
Original Assignee
JIANGSU ALPHA PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JIANGSU ALPHA PHARMACEUTICAL CO Ltd filed Critical JIANGSU ALPHA PHARMACEUTICAL CO Ltd
Priority to CN201810653383.0A priority Critical patent/CN108586427B/en
Publication of CN108586427A publication Critical patent/CN108586427A/en
Application granted granted Critical
Publication of CN108586427B publication Critical patent/CN108586427B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention belongs to field of medicine and chemical technology, more particularly to pharmaceutical field, more particularly to the preparation method of Atorvastatin calcium intermediate, by the way that compound ii is first prepared into lithium reagent, it is reacted again with methylchloroformate, introduce ester group, it is ester group-aminated at amide, dehydration of amide, finally reduction cyano obtains preparation among target compound this completely new Atorvastatin calcium, synthesis compound VI can be prepared under the premise of without using extremely toxic substances such as hydrogen cyanide, hydrohalogenic acid salts, and utilizes VI prepare compound I of compound.Reagent safety employed in whole preparation process, environmental protection, is a kind of preparation method more suitable for industrialized production.

Description

The preparation method of Atorvastatin calcium intermediate
Technical field
The invention belongs to field of medicine and chemical technology, more particularly to pharmaceutical field, and in particular to Atorvastatin calcium intermediate Preparation method.
Background technology
Atorvastatin calcium(Atorvastatin Calcium)By Warner-Lambert(Now it is incorporated to Pfizer)Development is opened Hair obtained FDA approvals in 1996 and is listed in the U.S., is mainly applicable to treatment hypercholesterolemia and mixed type hyperlipidemia Disease.
(4R-Cis) -6- aminoethyl -2,2- dimethyl -1,3- dioxolanes-hecanoic acid t-butyl ester(125995-13-3)(Change Close object I)It is crucial midbody compound in Atorvastatin calcium synthesis.
Currently, the synthesis route that the preparation method of chemical compounds I follows substantially is:
Therefore, the key intermediate compound that compound VI is synthesized as chemical compounds I, in the preparation work of Atorvastatin calcium There is important research significance, synthetic method, synthesis technology are current Atorvastatin calcium study on the synthesis in skill R&D process In hot issue.
Currently, there are two main classes for the preparation method of compound VI, first kind method is using double hydroxyls after first cyano substitution Protection, the second class method are cyano substitutions after first double hydroxyl protections.
It can be seen that although both preparation methods are different on yield and reaction condition, for example for method one For, yield can reach 81%, and for method two, yield is only capable of reaching 11%, while temperature is reacted in method two Degree requires 100 DEG C, and the reaction time even requires 30 hours.But both methods is there are one common ground in synthesis technology, Two methods are required for using NaCN.And during synthesis, it is also necessary to use hydrogen cyanide equal solvent as reaction medium.
For those skilled in the art, hydrogen cyanide, hydrohalogenic acid salt etc. belong to extremely toxic substance.These substances are not only right Human body is very harmful, and seriously pollutes environment.Using hydrogen cyanide, hydrohalogenic acid salt as reaction raw materials, current state is not met not only The main trend of family's environmental protection, and also be difficult to buy.This just further increases the manufacturing cost of compound VI, to further increase The manufacturing cost of Atorvastatin calcium is added.
Therefore, in the case that research and development are without using extremely toxic substances such as hydrogen cyanide, hydrohalogenic acid salts, how compound is prepared VI has great importance.
Invention content
The technical problem to be solved by the present invention is under the premise of without using hydrogen cyanide, hydrohalogenic acid salt, provide a kind of new The synthetic route of the preparation method of Atorvastatin calcium intermediate, this method is as follows:
It is further preferred that the preparation method can be specifically described as including the following steps:
The first step:Compound III is obtained by the reaction with synthesis in compound II;
Second step:Under cryogenic conditions, methylchloroformate is mixed with compound III, then increases temperature to room temperature, compound Compound IV is obtained by the reaction with methylchloroformate in III;
Third walks:Under alkaline condition, compound V is obtained by the reaction in the methanol solution of compound IV and ammonia;
4th step:For compound V under the action of dehydrating agent, dehydration generates compound VI.
Preferably, above-mentioned first step reaction is in ether, tetrahydrofuran, Isosorbide-5-Nitrae-dioxane, dichloromethane, toluene, two A kind of solution in toluene or optional two kinds and the two or more in the mixed solvents obtained according to the mixing of arbitrary mixed proportion into Row reaction.
It is further preferred that above-mentioned first step reaction is reacted in ether or tetrahydrofuran solution.
When first step reaction dissolvent selects ether or tetrahydrofuran, reaction temperature is -5-10 DEG C.
Preferred technical solution is that the methylchloroformate is molten to methylchloroformate with the compound III modes mixed Compound III is added dropwise in liquid.
Preferably, further include being quenched after the completion of second step reacts, extract, dry, concentration.
Further preferred technical solution is that the cryogenic conditions refer to -30 DEG C ~ 0 DEG C.
Wherein further preferred technical solution is that the solvent of methylchloroformate solution is ether, tetrahydrofuran, Isosorbide-5-Nitrae- The mixing that one or more of dioxane, dichloromethane, toluene, dimethylbenzene are mixed to form according to arbitrary mixed proportion Solvent.
The room temperature refers to 15 ~ 25 DEG C.
More preferably technical solution is that the cryogenic conditions refer to -20 DEG C.
And it is further preferred that the solvent of methylchloroformate solution is ether or tetrahydrofuran.
In a preferred technical solution, third step in be into the organic solution of compound IV be added ammonia methanol it is molten Liquid is reacted.
Preferably, after the completion of three-step reaction, further include removing solvent, extract, dry, concentration.
The methanol solution of ammonia mentioned here can be the methanol that ammonia is dissolved in the saturated ammonia formed in methanol solution Solution can also be the methanol solution that ammonium hydroxide is mixed to the ammonia obtained with methanol solution.
More preferably scheme is that the reaction temperature of three-step reaction is 15 ~ 100 DEG C.
Further preferred technical solution is that compound V is dissolved in organic solvent, in the effect of alkaline matter and dehydrating agent Under, dehydration generates compound VI.
The wherein described organic solvent be preferably dichloromethane, 1,2- dichloroethanes, acetonitrile, n,N-Dimethylformamide, The mixture of one or more of dimethyl sulfoxide (DMSO), benzene,toluene,xylene arbitrary proportion mixing.The wherein alkali Property substance is preferably at least one of pyridine, 4-dimethylaminopyridine, sodium carbonate, potassium carbonate, sodium hydroxide or potassium hydroxide. Wherein the dehydrating agent is that thionyl chloride, one kind in phosphorus oxychloride or thionyl chloride and phosphorus oxychloride are mixed according to arbitrary proportion Close the mixture obtained.
Further, invention additionally discloses the methods of VI prepare compound I of compound is:Compound VI is dissolved in organic molten Agent is reacted with hydrogen under the effect of the catalyst, obtains compound I.
It is further preferred that the reaction is described as, having for catalyst is added in the organic solvent solution of compound VI The molten solution of machine carries out hydrogenation, after the completion of reaction, filters, and concentration is diluted with water, liquefied ammonia tune PH, is extracted, dry, concentration, Obtain corresponding compound I.
Wherein preferred, the catalyst is palladium carbon, platinum carbon, one or two kinds of any of the above ratio of Raney's nickel Mixture.The organic solvent is the alcohols such as methanol, ethyl alcohol, propyl alcohol, formic acid, acetic acid, propionic acid it is one or two kinds of more than The mixture of arbitrary mixed proportion mixing.
In a preferred technical solution, catalyst is preferably palladium carbon or platinum carbon.
In another preferred technical solution, organic solvent is preferably acetic acid.
Further, invention additionally discloses preferred compound VI and hydrogen, under the effect of the catalyst, in 20-30 DEG C of item It is reacted under part.
The present invention, which breaches, must use the plays such as hydrogen cyanide, hydrohalogenic acid salt in production procedure among traditional Atorvastatin calcium The predicament of noxious material.It, can be without using hydrogen cyanide, hydrohalogenic acid salt etc. by preparation among completely new Atorvastatin calcium Synthesis compound VI is prepared under the premise of extremely toxic substance, and utilizes VI prepare compound I of compound.It is adopted in whole preparation process With reagent safety, environmental protection, is a kind of preparation method more suitable for industrialized production.
Specific implementation mode
In order to better understand the present invention, below we the present invention will be further elaborated in conjunction with specific embodiments.
Each embodiment agents useful for same is commercial product unless otherwise indicated.
Embodiment 1
At 0 DEG C, by lithium metal(0.18g)40mL anhydrous ethers are dissolved in, compound ii is slowly added dropwise thereto(2.79g 0.01mol)Diethyl ether solution 10ml, stir at 0 DEG C, generated with white precipitate in reaction, reaction until lithium after the reaction was complete, It stands, takes the supernatant containing compound III for reacting in next step.
By methylchloroformate(1.09g 0.012mol)It is dissolved in 10ml anhydrous ethers, under conditions of -20 DEG C thereto The supernatant containing compound III obtained in abovementioned steps is added dropwise(The diethyl ether solution of compound III), after being added dropwise to complete, rise to Room temperature(15~25℃), stir to reaction and terminate.Then it is cooled to 0 DEG C, and 6.5mL is added into the solution after reaction and is saturated chlorine Change ammonium salt solution, the hydrochloric acid 2.2ml that mass percent is 10% is then added, retains organic layer, is washed with 5% sodium bicarbonate, rotates Ether is removed, 2.11g compounds Ⅳs are obtained(Purity 93%, yield 70%).Characterization of The Products data are as follows:1H-NMR (400 MHz, CDCl3) δ 4.49 – 4.37 (m, 2H), 3.70 (s, 3H), 2.62-2.53 (m, 2H), 2.40-2.32 (m, 2H), 1.86-1.77 (m, 2H), 1.42 (s, 9H), 1.21 (s, 6H). 13C-NMR (100 MHz, CDCl3) δ 172.92, 171.80, 100.80, 81.86, 69.53, 51.87, 42.07, 41.03, 35.33, 28.33, 26.21 .
By compounds Ⅳ(6.25g 0.02mol)With NH3H2O(200mL)/MeOH(200mL)Solution is stirred at room temperature about 16 Hour, after reaction, major part MeOH is removed, is diluted with water and is extracted with DCM.Combined organic layer is washed with brine, It is dried and concentrated with anhydrous sodium sulfate, obtains compound V(1.45g 85%).Characterization of The Products data are as follows:1H-NMR (400 MHz, CDCl3) δ 5.61 (s, 2H), 4.49 – 4.36 (m, 1H), 4.16 – 4.04 (m, 1H), 2.65 – 2.56 (m, 1H), 2.56 – 2.47 (m, 1H), 2.43 – 2.36 (m, 1H), 2.34-2.26 (m, 1H), 1.83 – 1.70 (m, 1H), 1.57-1.52 (m, 1H), 1.42 (s, 9H), 1.21 (s, 6H).13C-NMR (100 MHz, CDCl3) δ 175.73, 172.92, 100.80, 81.86, 73.66, 69.53, 45.59, 41.03, 35.33, 28.33, 26.21。
By compound V(4.31g,0.015mol)It is dissolved in toluene(25mL)In, pyridine is added(0.5mL)And thionyl chloride (0.5mL), it is stirred at room temperature overnight, then uses water, sodium bicarbonate aqueous solution and salt water washing respectively, be dried and concentrated. To compound VI(3.23g 80%).Characterization of The Products data are as follows:1H-NMR (400 MHz, CDCl3) δ 4.47-4.44 (m, 2H), 2.92-2.88(m, 1H), 2.77-2.70 (m, 1H), 2.60-2.56 (m, 1H), 2.40-2.32 (m, 1H), 2.00-1.92 (m, 1H), 1.82-1.74 (m, 1H), 1.42 (s, 9H), 1.21 (s, 6H).13C-NMR (100 MHz, CDCl3) δ 172.92, 171.80, 100.80, 81.86, 69.53, 51.87, 42.07, 41.03, 35.33, 28.33, 26.21。
In reaction kettle, compound VI is first added(5g), acetic acid 50ml adds 10% palladium carbon(0.5g)Acetic acid solution (5ml), 20-30 DEG C of hydrogenation 8h.After the completion of reaction, diatomite filtering rotates filtrate, obtains grease.Grease is molten In 30ml water, pH is adjusted to 8-9 with liquefied ammonia, is then extracted with dichloromethane.By dichloromethane layer separation and with anhydrous sulphur Sour sodium is dry and rotates, and obtains chemical compounds I(4.62g 91%).Characterization of The Products data are as follows:1H-NMR (400 MHz, CDCl3): δ4.23-4.19 (m, 1H),3.99-3.95 (m, 1H), 2.74 (t, J =7.1 Hz, 2H), 2.40- 2.36 (m, 1H),2.27-2.22 (m,1H), 1.58-1.41 (m, 2H),1.40 (s, 9H), 1.31 (s, 6H), 0.89 (s, 9H). 13C-NMR (100 MHz, CDCl3) δ 172.92, 100.80, 81.86, 69.53, 67.23, 41.03, 40.00, 39.23, 35.55, 28.33, 26.21。
Embodiment 2
At 0 DEG C, by lithium metal(0.18g)40mL anhydrous tetrahydro furans are dissolved in, compound ii is slowly added dropwise thereto(2.79g 0.01mol)Tetrahydrofuran solution 10ml, stir at 0 DEG C, generated with white precipitate in reaction, reaction is until lithium has reacted Quan Hou is stood, and takes the supernatant containing compound III for reacting in next step.
By methylchloroformate(1.09g 0.012mol)It is dissolved in 10ml anhydrous tetrahydro furans.Under conditions of -20 DEG C to The supernatant containing compound III obtained in abovementioned steps is wherein added dropwise(The tetrahydrofuran solution of compound III), it is warmed to room temperature (15~25℃), stirring, after reaction, 10% hydrochloric acid is then added in addition 6.5mL saturated ammonium chloride solutions at 0 DEG C 2.2ml retains organic layer, is washed with 5% sodium bicarbonate, and revolving removes tetrahydrofuran, obtains 2.05g compounds Ⅳs(Purity 92%, Yield 68%).
By compounds Ⅳ(6.25g 0.02mol)With NH3H2O(200mL)/MeOH(200mL)Solution is stirred at room temperature About 16 hours, after reaction, major part MeOH is removed, is diluted with water and is extracted with DCM.Combined organic layer is washed with salt It washs, is dried and concentrated with anhydrous sodium sulfate, obtain compound V(1.45g 85%).
Compound V(4.31g,0.015mol)It is dissolved in toluene(25mL)In, pyridine is added(0.5mL)And thionyl chloride (0.5mL), it is stirred at room temperature overnight, then uses water, sodium bicarbonate aqueous solution and salt water washing respectively, be dried and concentrated. To compound VI(3.23g 80%).
In reaction kettle, compound VI is first added(5g), acetic acid 50ml adds 10% platinum carbon(0.5g)Acetic acid solution (5ml), 20-30 DEG C of hydrogenation 8h.After the completion of reaction, diatomite filtering rotates filtrate, obtains grease.Grease is molten In 30ml water, pH is adjusted to 8-9 with liquefied ammonia, is then extracted with dichloromethane.By dichloromethane layer separation and with anhydrous sulphur Sour sodium is dry and rotates, and obtains chemical compounds I(4.57g 90%).
Embodiment 3
At 0 DEG C, by lithium metal(0.18g)40mL anhydrous ethers are dissolved in, compound ii is slowly added dropwise thereto(2.79g 0.01mol)Diethyl ether solution 10ml, stir at 0 DEG C, generated with white precipitate in reaction, reaction until lithium after the reaction was complete, It stands, takes the supernatant containing compound III for reacting in next step.
By methylchloroformate(1.09g 0.012mol)It is dissolved in 10ml anhydrous ethers.Under conditions of -20 DEG C thereto The supernatant containing compound III obtained in abovementioned steps is added dropwise(The diethyl ether solution of compound III), it is warmed to room temperature(15~25 ℃), stir, after reaction, saturated ammonium chloride solution be added at 0 DEG C, 10% hydrochloric acid 2.2ml is then added, retains organic Layer, is washed with 5% sodium bicarbonate, and revolving removes ether, obtains 2.11g compounds Ⅳs(Purity 93%, yield 70%).
Compounds Ⅳ(6.25g 0.02mol)In, excessive saturation NH is added3/ MeOH solution, is stirred at room temperature about 16 Hour, after reaction, major part MeOH is removed, is diluted with water and is extracted with DCM.Combined organic layer is washed with brine, It is dried and concentrated with anhydrous sodium sulfate, obtains compound V(1.42g 83.3%).
Compound V(4.31g,0.015mol)It is dissolved in toluene(25mL)In, pyridine is added(0.5mL)And thionyl chloride (0.5mL), it is stirred at room temperature overnight, then uses water, sodium bicarbonate aqueous solution and salt water washing respectively, be dried and concentrated. To compound VI(3.23g 80%).
In reaction kettle, compound VI is first added(5g), formic acid 50ml adds 10% platinum carbon(0.5g)Formic acid solution (5ml), 20-30 DEG C of hydrogenation 8h.After the completion of reaction, diatomite filtering rotates filtrate, obtains grease.Grease is molten In 30ml water, pH is adjusted to 8-9 with liquefied ammonia, is then extracted with dichloromethane.By dichloromethane layer separation and with anhydrous sulphur Sour sodium is dry and rotates, and obtains chemical compounds I(4.62g 91%).
Embodiment 4
It is tested according to mode disclosed in embodiment 1-3, unlike embodiment 1-3.In the present embodiment, right respectively Solvent and reaction temperature in first step reaction are replaced.
We are respectively with the grade ratios of 1,4- dioxane, dichloromethane, toluene, dimethylbenzene and ether and tetrahydrofuran Example mixed solution, ether and tetrahydrofuran 1:100(Volume ratio), ether and tetrahydrofuran 100:1(Volume ratio), toluene and dichloro Methane 1:100(Volume ratio), toluene and dichloromethane 100:1(Volume ratio)Etc. ether in solution forms alternative embodiment 1-3 Or tetrahydrofuran, the results show that solution disclosed by the invention may be incorporated for the solvent of first step reaction.
We replace 0 DEG C in the first step with -5 DEG C, -2 DEG C, 2 DEG C, 5 DEG C, 8 DEG C, 10 DEG C respectively and react, and as a result show Showing can react under the conditions of -5 DEG C~10 DEG C.
Embodiment 5
It is tested according to mode disclosed in embodiment 1-3, unlike embodiment 1-3.In the present embodiment, right respectively Solvent and reaction temperature in second step reaction are replaced.
We are respectively with -30 DEG C, -28 DEG C, -25 DEG C, -15 DEG C, -13 DEG C, -10 DEG C, -8 DEG C, -5 DEG C, 0 DEG C of replacement second step In -20 degrees Celsius.
As a result being shown in the range of -30 DEG C to 0 DEG C can react.
According to the reagent being added in the first step, corresponding addition Isosorbide-5-Nitrae-dioxane, dichloromethane in second step respectively The equal proportion mixed solution of alkane, toluene, dimethylbenzene and ether and tetrahydrofuran, ether and tetrahydrofuran 1:100(Volume Than), ether and tetrahydrofuran 100:1(Volume ratio), toluene and dichloromethane 1:100(Volume ratio), toluene and dichloromethane 100:1(Volume ratio)Etc. ether or tetrahydrofuran in solution forms alternative embodiment 1-3, the results show that the present invention discloses Solution may be incorporated for second step reaction solvent.
Embodiment 6
It is tested according to mode disclosed in embodiment 1-3, unlike embodiment 1-3.In the present embodiment, to third Reaction temperature in step reaction is replaced.
In the present embodiment respectively investigate 15 DEG C, 20 DEG C, 25 DEG C, 30 DEG C, 35 DEG C, 40 DEG C, 45 DEG C, 50 DEG C, 55 DEG C, 60 ℃、65℃、70℃、75℃、80℃、85℃、90℃、95℃、100℃。
As a result it may be implemented to react in the range of being shown in 15 DEG C ~ 100 DEG C.
Embodiment 7
It is tested according to mode disclosed in embodiment 1-3, unlike embodiment 1-3.In the present embodiment, to the 4th step Reaction temperature in reaction is replaced.
Respectively with dichloromethane, 1,2- dichloroethanes, acetonitrile, n,N-Dimethylformamide, dimethyl sulfoxide (DMSO), benzene, diformazan Benzene, the mixed solution of dichloromethane and toluene, acetonitrile and toluene mixed solution etc. replace the dissolving that toluene is used for compound V. The results show that solution disclosed in the present invention may be incorporated for the dissolving of compound V.
Pyridine is substituted with 4-dimethylaminopyridine, sodium carbonate, potassium carbonate, sodium hydroxide or potassium hydroxide respectively.As a result it shows Show, solution disclosed in the present invention may be incorporated for being formed the alkaline reaction environment of compound V.
Dichloro is replaced as dehydrating agent using phosphorus oxychloride and thionyl chloride and the arbitrary proportion mixture of phosphorus oxychloride respectively Sulfoxide, the results show that can obtain compound VI.
Embodiment 8
It is tested according to mode disclosed in embodiment 1-3, unlike embodiment 1-3.In the present embodiment, to compound The reaction condition of VI prepare compound I is replaced.
Respectively using the mixture of the mixture of platinum carbon, Raney's nickel and palladium carbon and platinum carbon, palladium carbon and Raney's nickel as catalysis Agent is used for VI prepare compound I of compound.The results show that catalyst disclosed by the invention may be incorporated for VI preparationization of compound Close object I.
Respectively with the arbitrary mixing ratio of the alcoholic solutions such as methanol, ethyl alcohol, propyl alcohol and formic acid, propionic acid or alcohol and acid solution The mixed solution that example obtains replaces acetic acid, the results show that solution disclosed by the invention may be incorporated for compound VI as solvent Prepare compound I.
The above is the specific implementation mode of the present invention.It should be pointed out that for those skilled in the art, Various improvements and modifications may be made without departing from the principle of the present invention, these improvements and modifications are also considered as this hair Bright protection domain.

Claims (10)

1. the preparation method of Atorvastatin calcium intermediate, it is characterised in that:The synthetic route of this method is as follows:
2. the preparation method of Atorvastatin calcium according to claim 1, feature exist:Include the following steps:
The first step:Compound III is obtained by the reaction with synthesis in compound II;
Second step:Under cryogenic conditions, methylchloroformate is mixed with compound III, then increases temperature to room temperature, compound Compound IV is obtained by the reaction with methylchloroformate in III;
Third walks:Under alkaline condition, compound V is obtained by the reaction in the methanol solution of compound IV and ammonia;
4th step:For compound V under the action of dehydrating agent, dehydration generates compound VI.
3. the preparation method of Atorvastatin calcium according to claim 2, it is characterised in that:It is preferably following in the first step Any one or several optimum conditions,
First step reaction is that one kind in ether, tetrahydrofuran, 1,4- dioxane, dichloromethane, toluene, dimethylbenzene is molten Liquid or two kinds optionally and the two or more in the mixed solvents obtained according to the mixing of arbitrary mixed proportion are reacted;Particularly preferably It is to be reacted in ether or tetrahydrofuran solution;
Reaction temperature is -5-10 DEG C.
4. the preparation method of Atorvastatin calcium according to claim 2, it is characterised in that:It is preferably following in second step Any one or several optimum conditions,
A. the methylchloroformate is that compound III is added dropwise into methylchloroformate solution with the compound III modes mixed;
B. further include being quenched after the completion of second step reacts, extract, dry, concentration;
C. the cryogenic conditions refer to -30 DEG C ~ 0 DEG C, particularly preferably -20 DEG C;
D. the solvent of methylchloroformate solution is ether, tetrahydrofuran, 1,4- dioxane, dichloromethane, toluene, dimethylbenzene One or more of the mixed solvent that is mixed to form according to arbitrary mixed proportion, wherein particularly preferred methylchloroformate The solvent of solution is ether or tetrahydrofuran.
5. the preparation method of Atorvastatin calcium according to claim 2, it is characterised in that:It is preferably following in the third step Any one or several optimum conditions,
A. third step in be into the organic solution of compound IV be added ammonia methanol solution reacted;
B. after the completion of three-step reaction, further include removing solvent, extract, dry, concentration;
C. the methanol solution of the ammonia is the methanol solution that ammonia is dissolved in the saturated ammonia formed in methanol solution, either Ammonium hydroxide is mixed to the methanol solution of the ammonia obtained with methanol solution;
D. the reaction temperature of three-step reaction is 15 ~ 100 DEG C.
6. the preparation method of Atorvastatin calcium according to claim 2, it is characterised in that:Compound V is dissolved in organic molten Agent, under the action of alkaline matter and dehydrating agent, dehydration generates compound VI.
7. the preparation method of Atorvastatin calcium according to claim 6, it is characterised in that:It is preferred that it is following any one or The several optimum conditions of person:
A. organic solvent it is excellent for dichloromethane, 1,2- dichloroethanes, acetonitrile, n,N-Dimethylformamide, dimethyl sulfoxide (DMSO), The mixture of one or more of benzene,toluene,xylene arbitrary proportion mixing;
B. alkaline matter be pyridine, 4-dimethylaminopyridine, sodium carbonate, potassium carbonate, sodium hydroxide or potassium hydroxide at least It is a kind of;
C. dehydrating agent is that thionyl chloride, one kind in phosphorus oxychloride or thionyl chloride are mixed with phosphorus oxychloride according to arbitrary proportion The mixture of acquisition.
8. the preparation method of Atorvastatin calcium according to claim 1, which is characterized in that further include prepared by compound VI The method of compound I:Compound VI is dissolved in organic solvent, under the effect of the catalyst, is reacted with hydrogen, obtains compound I.
9. the preparation method of Atorvastatin calcium according to claim 8, it is characterised in that:In the organic molten of compound VI Organic molten solution that catalyst is added in agent solution carries out hydrogenation, after the completion of reaction, filters, and concentration is diluted with water, liquid Ammonia tune PH is extracted, dry, and concentration obtains corresponding compound I.
10. the preparation method of Atorvastatin calcium according to claim 8, which is characterized in that preferably it is following any one Or several optimum conditions:
A. the catalyst is the mixture of palladium carbon, platinum carbon, one or two kinds of any of the above ratio of Raney's nickel;Especially Preferably palladium carbon or platinum carbon;
B. the organic solvent is the alcohols such as methanol, ethyl alcohol, propyl alcohol, formic acid, acetic acid, propionic acid it is one or two kinds of more than The mixture of arbitrary mixed proportion mixing;Particularly preferably acetic acid;
C. compound VI and hydrogen react under conditions of 20-30 DEG C under the effect of the catalyst.
CN201810653383.0A 2018-06-22 2018-06-22 Preparation method of atorvastatin calcium intermediate Active CN108586427B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810653383.0A CN108586427B (en) 2018-06-22 2018-06-22 Preparation method of atorvastatin calcium intermediate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810653383.0A CN108586427B (en) 2018-06-22 2018-06-22 Preparation method of atorvastatin calcium intermediate

Publications (2)

Publication Number Publication Date
CN108586427A true CN108586427A (en) 2018-09-28
CN108586427B CN108586427B (en) 2020-08-11

Family

ID=63633985

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810653383.0A Active CN108586427B (en) 2018-06-22 2018-06-22 Preparation method of atorvastatin calcium intermediate

Country Status (1)

Country Link
CN (1) CN108586427B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114181188A (en) * 2021-12-08 2022-03-15 江苏阿尔法药业股份有限公司 Non-solvation synthesis method of atorvastatin calcium intermediate

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107778279A (en) * 2017-11-13 2018-03-09 江苏欧信制药有限公司 A kind of preparation method of Atorvastatin calcium intermediate

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107778279A (en) * 2017-11-13 2018-03-09 江苏欧信制药有限公司 A kind of preparation method of Atorvastatin calcium intermediate

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
FANG-JUN XIONG等: "《An improved process for chiron synthesis of the atorvastatin side》", 《TETRAHEDRON ASYMMETRY》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114181188A (en) * 2021-12-08 2022-03-15 江苏阿尔法药业股份有限公司 Non-solvation synthesis method of atorvastatin calcium intermediate

Also Published As

Publication number Publication date
CN108586427B (en) 2020-08-11

Similar Documents

Publication Publication Date Title
CN103880625B (en) Method for preparing D, L-mandelic acid and derivative of D, L-mandelic acid
CN101462935B (en) Process for synthesizing alpha-bromoacetophenone compound
CN101863858A (en) Synthetic method of bentazone
CN101171251A (en) Process for making aztreonam
CN108586427A (en) The preparation method of Atorvastatin calcium intermediate
KR101595747B1 (en) Method for preparing of nafamostat mesilate
Wang et al. Synthesis of difluorinated β-and γ-amino acids: Investigation of a challenging deoxyfluorination reaction
CN106749071B (en) A kind of preparation method of aromatics 1,2,4,5- tetrazine compound
US9695125B2 (en) Method for synthesizing cationic bleach activators via a single-bath reaction
CN105712919A (en) Application of amide condensing agent in vildagliptin synthetic method
WO2017205622A1 (en) Method of making benznidazole
CN108299466B (en) Improved dolutegravir synthesis method
CN111072660B (en) Simple preparation method of rilibatan
CN102382026A (en) Environmentally-friendly synthesis process of Aztreonam main ring (3S-trans)-3-amino-4-methyl-2-oxo-1-azetidinyl sulfonic acid
CN105884644A (en) Advantage forms and preparation method of neutral endopeptidase inhibitor salt
CN106946724B (en) The synthetic method of monoamine base inhibitor class intermediate 2- acetylaminohydroxyphenylarsonic acid 2- benzyl malonic acid mono ethyl ester
CN102603543B (en) Preparation method of mexiletine hydrochloride
CN107129440B (en) A kind of total synthesis method of natural products (+)-negamycin
CN111892544A (en) 3- (aminomethyl) -4- (4-fluorophenyl) piperazine-1-carboxylic acid tert-butyl ester and synthesis method thereof
CN106279114B (en) A kind of synthetic method of Taladegib
CN107089928A (en) The synthetic method of N Boc L propargylglycines
CN108640861A (en) " one kettle way " that alkynyl amide mediates prepares macrolide
CN103254268A (en) Process for preparing dutasteride
CN109983011A (en) The manufacturing method of polymerizable compound
CN115073252B (en) 13C Mexaxetine and synthesis method of 13C phenacetin

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP01 Change in the name or title of a patent holder
CP01 Change in the name or title of a patent holder

Address after: 223800 No.5 Yanshan Road, eco Chemical Technology Industrial Park, Suqian City, Jiangsu Province

Patentee after: Jiangsu alpha Pharmaceutical Co.,Ltd.

Address before: 223800 No.5 Yanshan Road, eco Chemical Technology Industrial Park, Suqian City, Jiangsu Province

Patentee before: ALPHA PHARMACEUTICAL Co.,Ltd. JIANGSU PROVINCE